Ewing Sarcoma
Links shared publicly online about this topic.
- 1,857total visits
Ewing Sarcoma
View full resource at kidshealth.org
Tags: Cancer, Children's Health
Most Recently Shared on July 31, 2009 at 2:44 pm By:
Come Together, Right Now: The Desperate Need for Integration in Biomedicine - David Ewing Duncan - Health - The Atlantic
theatlantic.com — “Two speakers at TEDMED, 82 year-old E.O. Wilson and 34 year-old Jacob Scott, call for a balancing of experts and generalists in life sciences” View full resource at theatlantic.com
Most Recently Shared on April 13, 2012 at 2:11 am By:
David Basanta PhD and Doctor
Do we have room for generalists in biomedical sciences? Jacob Scott thinks not http://t.co/bgfdV1cJ
2 targeted therapies act against Ewing's sarcoma tumors | Science Codex
sciencecodex.com — “CHICAGO - A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson Cancer Center” View full resource at sciencecodex.com
Most Recently Shared on April 1, 2012 at 1:59 pm By:
Bruce Shriver Patient Advocate, PhD, Doctor, and Health Advocate
2 targeted therapies act against Ewing's sarcoma tumors - http://t.co/bwkMAS4b
Call for Applications
sites.kauffman.org — “The Ewing Marion Kauffman Foundation: catalyzing entrepreneurial success in business, education and social innovation.” View full resource at sites.kauffman.org
Most Recently Shared on March 27, 2012 at 4:34 pm By:
FasterCures Health Organization
Calling all life sciences entrepreneurs: Apply to be a part of inaugural @Kauffmanfdn Life Sciences Ventures Summit. http://t.co/Tie3AVMb
Confdetail393 : European Science Foundation
esf.org — “The European Science Foundation promotes high quality science at a European level. It acts as a catalyst for the development of science by bringing together leading scientists and funding agencies to debate, plan and implement pan-European initiatives.” View full resource at esf.org
Most Recently Shared on March 26, 2012 at 8:40 am By:
Bruce Shriver Patient Advocate, PhD, Doctor, and Health Advocate
Molecular Biology & Innovative Therapies in Sarcomas of Childhood & Adolescence - http://t.co/6lFm6GXR
Inside Americas Drug Shortage: Scrambling for a Solution | KTVQ.com | Q2 | Billings, Montana
ktvq.com — “When Rebecca Robinson showed up at the hospital expecting to receive her infusion of Doxil, a chemotherapy drug, last July, her doctors delivered the shocking news that they didn't have any more of the drug. Supplies of Doxil, a cornerstone for treating cancers known as sarcomas, had fallen short nationwide, along with methotrexate, a drug for treating childhood cancer, after one of the largest domestic suppliers of the drug shut down its plant over quality-control issues. What happened to Robin” View full resource at ktvq.com
Most Recently Shared on March 26, 2012 at 7:10 am By:
Bruce Shriver Patient Advocate, PhD, Doctor, and Health Advocate
Inside Americas Drug Shortage: Scrambling for a Solution - Sarcoma Mentioned - http://t.co/sXbImpCZ
AACR Congratulates Co-founder of Stand Up To Cancer Lisa Paulsen on Receiving the Society of Surgical Oncology's James Ewing Layman Award
aacr.org — “PHILADELPHIA — The American Association for Cancer Research congratulates Lisa Paulsen, president and chief executive officer of the Entertainment Industry Foundation and co-founder of Stand Up To Cancer (SU2C), on receiving the James Ewing Layman Award. The Society of Surgical Oncology is honoring Paulsen with the award for her efforts to eradicate cancer through her leadership of the Entertainment Industry Foundation (EIF), especially her major role in establishing Stand Up To Cancer. &l” View full resource at aacr.org
Most Recently Shared on March 23, 2012 at 9:40 pm By:
Raymond DuBois Internist, Gastroenterologist, Health Executive, Physician, and Doctor
Co-founder Stand Up To Cancer Lisa Paulsen on Receiving the Society of Surgical Oncology's James Ewing Layman Award: http://t.co/wZShebq2
ToyotaUSA - YouTube
youtube.com — “Welcome to the official YouTube channel of Toyota USA.” View full resource at youtube.com
Most Recently Shared on March 23, 2012 at 3:15 am By:
4 cool techno-wizardry see “Tech Talk” hosted by one & only Bill Nyethe Science Guy #Priusc http://t.co/yWDwEweG #ToyotaWomen
Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote on Investigational Medicine Ridaforolimus for the Treatment of Metastatic Soft-Tissue or Bone Sarcomas
drugs.com — “Ridaforolimus is a new drug in development for the treatment of metastatic soft-tissue or bone sarcomas. Ridaforolimus information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on March 23, 2012 at 2:08 am By:
Drugs and Devices OW OW Health
Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote on Investigational Medicine ... http://t.co/4KhlrDqV #drug
ODAC rejects ridaforolimus as maintenance therapy for sarcoma | HemOncToday
hemonctoday.com — “An FDA panel rejected ridaforolimus as a maintenance therapy for patients with soft-tissue or bone ” View full resource at hemonctoday.com
Most Recently Shared on March 21, 2012 at 5:10 pm By:
HemOnc Today Oncology and Health News
ODAC rejects ridaforolimus as maintenance therapy for sarcoma: http://t.co/wgR3AMi1
ingentaconnect Methotrexate: Breast cancer and Kaposi's sarcoma in an elderly pa...
ingentaconnect.com — “ingentaconnect Methotrexate: Breast cancer and Kaposi's sarcoma in an elderly pa...” View full resource at ingentaconnect.com
Most Recently Shared on March 21, 2012 at 5:07 pm By:
Methotrexate: Breast cancer and Kaposi's sarcoma in an elderly patient: case report: (Source: Reactions)MedWorm ... http://t.co/E7IjUGxv
ODAC Recommends Pazopanib But Not Ridaforolimus for Sarcomas
onclive.com — “ODAC has recommended the approval of pazopanib but ruled against the agent ridaforolimus to treat sarcomas.” View full resource at onclive.com
Most Recently Shared on March 21, 2012 at 4:26 pm By:
ODAC Recommends Pazopanib But Not Ridaforolimus for Sarcomas http://t.co/EuES1dWT
Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote on Investigational Medicine Ridaforolimus for the Treatment of Metastatic Soft-Tissue or Bone Sarcomas - Drugs.com MedNews
drugs.com — “(BUSINESS Mar 20, 2012 - Merck (NYSE MRK), known as MSD outside the United States and Canada, and ARIAD Pharmaceuticals, Inc., (NASDAQ ARIA), announced today th” View full resource at drugs.com
Most Recently Shared on March 21, 2012 at 12:06 pm By:
Drugs and Devices OW OW Health
Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote on Investigational Medicine ... http://t.co/aWVRi9MI #drug
FDA ODAC votes in favour of GSK's Votrient
news-medical.net — “GlaxoSmithKline announced today that the Oncologic Drugs Advisory Committee (ODAC) to the US FDA voted 11 to 2 that evidence from clinical studies support a favourable benefit – risk assessment for use of Votrient in treating patients with advanced soft tissue sarcoma who have received prior chemotherapy, noting that those with gastrointestinal stromal tumours (GIST) and adipocytic sarcomas were not included in the Phase III trial.” View full resource at news-medical.net
Most Recently Shared on March 21, 2012 at 10:23 am By:
FDA ODAC votes in favour of GSK's Votrient: GlaxoSmithKline announced today that the Oncologic Drugs Advisory Co... http://t.co/1qoZMRxM
Medical News:FDA Panel Offers Split Decision on Sarcoma Drugs - in Oncology/Hematology, Leukemia from MedPage Today
medpagetoday.com — “Medical News:FDA Panel Offers Split Decision on Sarcoma Drugs - in Oncology/Hematology, Leukemia from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on March 21, 2012 at 3:38 am By:
George Huba, Ph.D. PhD, Doctor, and Psychologist
FDA Panel Offers Split Decision on Sarcoma Drugs: WASHINGTON (MedPage Today) -- An FDA advisory committee is rec... http://t.co/9BSNOyLm
Medical News:FDA Panel Offers Split Decision on Sarcoma Drugs - in Oncology/Hematology, Leukemia from MedPage Today
medpagetoday.com — “Medical News:FDA Panel Offers Split Decision on Sarcoma Drugs - in Oncology/Hematology, Leukemia from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on March 21, 2012 at 2:35 am By:
#FDA Panel Offers Split Decision on #Sarcoma Drugs http://t.co/8r3x0Ye0
Advertisement
